Regenerative Medicine Industry Analysis and Outlook 2024-2034: Oncology Applications Lead the Forecasted $168 Billion Global Market [Yahoo! Finance]
Integra LifeSciences Holdings Corporation (IART)
Last integra lifesciences holdings corporation earnings: 2/19 06:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.integralife.com
Company Research
Source: Yahoo! Finance
to 2024-2034: Market By Product; By Application; By End-user; and By Region" report has been added to ResearchAndMarkets.com's offering. The global landscape of regenerative medicine is witnessing a transformative shift. This report meticulously segments the market by product, application, end-user, and region, offering insights into trends, growth drivers, and market dynamics. The projected expansion of the regenerative medicine market, estimated at USD 30.44 billion in 2023 and anticipated to reach USD 168 billion by 2034, underscores an impressive CAGR of 16.80%. The integration of advanced biological therapies and personalized medicine stands at the nexus of this burgeoning domain, with regenerative therapies shaping the future of disease treatment and management. Key Market Segments Leading Growth Product Development: Therapeutics remain the dominant revenue contributor, supported by an escalating number of regulatory approvals and an aging global population susceptible t
Show less
Read more
Impact Snapshot
Event Time:
IART
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IART alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IART alerts
High impacting Integra LifeSciences Holdings Corporation news events
Weekly update
A roundup of the hottest topics
IART
News
- Integra LifeSciences Holdings Co. (NASDAQ: IART) was downgraded by analysts at StockNews.com from a "buy" rating to a "hold" rating.MarketBeat
- Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific Meeting [Yahoo! Finance]Yahoo! Finance
- Integra LifeSciences to Spotlight CereLink® Intracranial Pressure (ICP) Monitoring System at the American Association of Neurological Surgeons (AANS) Annual Scientific MeetingGlobeNewswire
- Integra LifeSciences to Reschedule the First Quarter 2024 Financial Results Conference Call to May 6, 2024GlobeNewswire
- Here's Why Investors Should Retain Integra (IART) Stock Now [Yahoo! Finance]Yahoo! Finance
IART
Earnings
- 2/28/24 - Miss
IART
Sec Filings
- 4/4/24 - Form ARS
- 4/4/24 - Form DEF
- 3/25/24 - Form PRE
- IART's page on the SEC website